Medlife to cease operations, merge with PharmEasy this week

Indian online pharmacy and telemedicine startup PharmEasy, on Tuesday, announced its merger with competitor Medlife starting 25 May, 2021. Both companies’ plans of a merger first came to light in August last year, when PharmEasy had submitted a proposal to the Competition Commission of India (CCI) for acquiring Medlife.

The deal saw API Holdings, the parent entity of PharmEasy, acquire 100% equity shares of Medlife. Medlife’s promoters have in return got a 19.95% stake in the merged entity, which is expected to be valued at $1 Bn.

PharmEasy cofounder Dhaval Shah wrote on LinkedIn that the merged entity will be India’s largest online healthcare delivery platform, serving over 2 million families every month.